A study to assess the safety, dose conversion and titration of Duragesic (fentanyl transdermal system) in pediatric subjects with chronic pain requiring opioid therapy.

Trial Profile

A study to assess the safety, dose conversion and titration of Duragesic (fentanyl transdermal system) in pediatric subjects with chronic pain requiring opioid therapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 May 2009

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 12 May 2009 Actual end date (Apr 2002) added as reported by ClinicalTrials.gov.
    • 12 May 2009 Actual initiation date (Feb 2000) added as reported by ClinicalTrials.gov.
    • 25 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top